Fertility and Sterility
Volume 91, Issue 2 , Pages 383-386, February 2009

The efficacy of the transfer of twice frozen-thawed embryos with the vitrification method

  • Yoko Kumasako, B.E.

      Affiliations

    • St. Luke Clinic, Tsumori, Oita, Japan
    • Corresponding Author InformationReprint requests: Yoko Kumasako, B.E., St. Luke Clinic, 5-Tomioka, Tsumori, Oita 870-0947, Japan (FAX: +81-97-568-6299).
    • ,
  • Eiko Otsu, M.En.

      Affiliations

    • St. Luke Clinic, Tsumori, Oita, Japan
    • ,
  • Takafumi Utsunomiya, M.D.

      Affiliations

    • St. Luke Clinic, Tsumori, Oita, Japan
    • ,
  • Yasuhisa Araki, Ph.D.

      Affiliations

    • The Institute for Advanced Reproductive Medical Technology, Setagun, Gunma, Japan

Received 27 August 2007; received in revised form 26 November 2007; accepted 26 November 2007. published online 25 February 2008.

Objective

To confirm the clinical benefits of recryopreserved, twice-thawed embryo transfer (ET).

Design

Retrospective study.

Setting

Private fertility clinic.

Patient(s)

Forty-nine women whose embryos had been refrozen after a previous frozen-thawed ET.

Intervention(s)

None.

Main Outcome Measure(s)

Comparison of implantation and pregnancy rates of twice-cryopreserved, twice-thawed embryos versus once-cryopreserved, once-thawed embryos.

Result(s)

The pregnancy rate per ET cycle was 27.8% in the refrozen group and 25.9% in the control group (no statistically significant difference). The implantation rate was 25.0% in the refrozen group and 19.3% in the control group (no statistically significant difference).

Conclusion(s)

The refreezing of supernumerary embryos can prevent ovarian hyperstimulation syndrome in stimulated patients and in those who have experienced repeated failed pregnancies. If unexpected supernumerary embryos are available for recryopreservation after frozen-thawed ET, these embryos may be revitrified for a future transfer.

Key Words: Supernumerary embryo, refrozen embryos, vitrification, OHSS, PCOS

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Y.K. has nothing to disclose. E.O. has nothing to disclose. T.U. has nothing to disclose. Y.A. has nothing to disclose.

PII: S0015-0282(07)04144-1

doi:10.1016/j.fertnstert.2007.11.079

Fertility and Sterility
Volume 91, Issue 2 , Pages 383-386, February 2009

Article Tools

* Image Usage & Resolution